Physician profile
Vivian Mclaughlin
NPI 1386606150
$867.77
in general payments reported to CMS, 2019-2025
11 companies · $373 in 2025
The $373 reported for 2025 was more than what 95% of Nurse Anesthetist, Certified Registered providers received nationally (typical 2025 total: $45.72).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $87.95 · 2022: $80.27 · 2023: $119 · 2024: $207 · 2025: $373.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $700.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $699.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $307.76 | 2022-2025 | |
| Janssen Biotech, INC. | $98.42 | 2021-2025 | Tremfya |
| Takeda Pharmaceuticals U.S.A., INC. | $92.59 | 2021-2025 | Entyvio |
| Qol Medical, LLC | $76.08 | 2021-2025 | Sucraid |
| Regeneron Healthcare Solutions, INC. | $73.55 | 2023-2025 | Dupixent |
| Lilly USA, LLC | $54.12 | 2024-2025 | Omvoh |
| Merck Sharp & Dohme LLC | $52.23 | 2021-2023 | Dificid |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $43.15 | 2022-2024 | Xifaxan, Trulance |
| Genzyme Corporation | $34.34 | 2024 | |
| Ironwood Pharmaceuticals, INC | $21.24 | 2021 | |
| Intercept Pharmaceuticals, INC. | $14.29 | 2023 | Ocaliva |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vivian Mclaughlin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.